Trygg Pharma acquires Epax

Epax is the world’s premier high concentrate omega-3 supplement manufacturer. Epax employs a total of 74 people. Trygg Pharma AS has agreed to pay NOK 561 million for the shares, and will in addition assume the net interest bearing debt of Epax. As of 31 December 2009, Epax’ net interest bearing debt was NOK 314 million. Trygg Pharma AS will receive the result from the operations in Epax from 1 January 2010. The purchase price will carry an interest of 6% p.a. from 20 September 2010 until completion of the transaction. In 2009, Epax’ revenues were NOK 315 million and EBITDA was NOK 90 million